Page 118 - Read Online
P. 118

Page 216                               Tutanov et al. Extracell Vesicles Circ Nucleic Acids 2023;4:195-217  https://dx.doi.org/10.20517/evcna.2023.17

               130.      Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions
                    as an intercellular adhesion molecule. Cell 1989;57:327-34.  DOI  PubMed
               131.      Chan CH, Stanners CP. Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members
                    CEACAM5 and CEACAM6. Curr Oncol 2007;14:70-3.  DOI  PubMed  PMC
               132.      Blumenthal RD, Hansen HJ, Goldenberg DM. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6
                    (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res 2005;65:8809-17.  DOI  PubMed
               133.      Beauchemin N, Arabzadeh A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and
                    metastasis. Cancer Metastasis Rev 2013;32:643-71.  DOI  PubMed
               134.      Gemei M, Mirabelli P, Di Noto R, et al. CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts
                    tumor growth in vivo. Cancer 2013;119:729-38.  DOI
               135.      Pinkert J, Boehm HH, Trautwein M, et al. T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1
                    interaction. Oncoimmunology 2022;11:2008110.  DOI
               136.      Sørensen CG, Karlsson WK, Pommergaard HC, Burcharth J, Rosenberg J. The diagnostic accuracy of carcinoembryonic antigen to
                    detect colorectal cancer recurrence - A systematic review. Int J Surg 2016;25:134-44.  DOI  PubMed
               137.      Kang Y, Zhu X, Lin Z, et al. Compare the diagnostic and prognostic value of MLR, NLR and PLR in CRC patients. Clin Lab
                    2021:67.  DOI
               138.      Ma Y, Zhang Y, Bi Y, et al. Diagnostic value of carcinoembryonic antigen combined with cytokines in serum of patients with
                    colorectal cancer. Medicine 2022;101:e30787.  DOI  PubMed  PMC
               139.      Wang, J, et al. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically
                    treated colorectal cancer patients. Int J Clin Exp Pathol 2015;8:14853-63.  PubMed  PMC
               140.      Xu Z, Wang H, Gao L, Zhang H, Wang X. YAP levels combined with plasma CEA levels are prognostic biomarkers for early-
                    clinical-stage patients of colorectal cancer. Biomed Res Int 2019;2019:2170830.  DOI  PubMed  PMC
               141.      Belov L, Matic KJ, Hallal S, Best OG, Mulligan SP, Christopherson RI. Extensive surface protein profiles of extracellular vesicles
                    from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles 2016;5:25355.  DOI  PubMed  PMC
               142.      Yokoyama S, Takeuchi A, Yamaguchi S, et al. Clinical implications of carcinoembryonic antigen distribution in serum exosomal
                    fraction-Measurement by ELISA. PLoS One 2017;12:e0183337.  DOI
               143.      Eddama MMR, Gurung R, Fragkos K, et al. The role of microvesicles as biomarkers in the screening of colorectal neoplasm. Cancer
                    Med 2022;11:2957-68.  DOI  PubMed  PMC
               144.      Lee CH, Im EJ, Moon PG, Baek MC. Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small
                    extracellular vesicles. BMC Cancer 2018;18:1058.  DOI  PubMed  PMC
               145.      Sun B, Li Y, Zhou Y, et al. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer. J Cell
                    Physiol 2019;234:1416-25.  DOI
               146.      Xiao Y, Zhong J, Zhong B, et al. Exosomes as potential sources of biomarkers in colorectal cancer. Cancer Lett 2020;476:13-22.
                    DOI
               147.      Ikeda A, Nagayama S, Sumazaki M, et al. Colorectal cancer-derived CAT1-positive extracellular vesicles alter nitric oxide
                    metabolism in endothelial cells and promote angiogenesis. Mol Cancer Res 2021;19:834-46.  DOI
               148.      Keyhani G, Mahmoodzadeh Hosseini H, Salimi A. Effect of extracellular vesicles of Lactobacillus rhamnosus GG on the expression
                    of CEA gene and protein released by colorectal cancer cells. Iran J Microbiol 2022;14:90-6.  DOI  PubMed  PMC
               149.      Wang S, Qiu Y, Bai B. The expression, regulation, and biomarker potential of glypican-1 in cancer. Front Oncol 2019;9:614.  DOI
                    PubMed  PMC
               150.      Lu F, Chen S, Shi W, Su X, Wu H, Liu M. GPC1 promotes the growth and migration of colorectal cancer cells through regulating the
                    TGF-β1/SMAD2 signaling pathway. PLoS One 2022;17:e0269094.  DOI  PubMed  PMC
               151.      Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature
                    2015;523:177-82.  DOI  PubMed  PMC
               152.      Papiewska-Pająk I, Krzyżanowski D, Katela M, et al. Glypican-1 level is elevated in extracellular vesicles released from MC38 colon
                    adenocarcinoma cells overexpressing snail. Cells 2020;9:1585.  DOI  PubMed  PMC
               153.      Li J, Chen Y, Guo X, et al. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of
                    colorectal cancer. J Cell Mol Med 2017;21:838-47.  DOI  PubMed  PMC
               154.      L Ramos T, Sánchez-Abarca LI, Muntión S, et al. MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived
                    extracellular vesicles by conventional flow cytometry. Cell Commun Signal 2016;14:2.  DOI  PubMed  PMC
               155.      Rabesandratana H, Toutant JP, Reggio H, Vidal M. Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis
                    (CD59) are released within exosomes during in vitro maturation of reticulocytes. Blood 1998; 91:2573-80.  DOI
               156.      Liu D, Liu F, Song YK. Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin.
                    Biochim Biophys Acta 1995;1235:140-6.  DOI
               157.      Wassef NM, Matyas GR, Alving CR. Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of
                    "stealth" lipids. Biochem Biophys Res Commun 1991;176:866-74.  DOI  PubMed
               158.      López-Cobo S, Campos-Silva C, Valés-Gómez M. Glycosyl-phosphatidyl-inositol (GPI)-anchors and metalloproteases: their roles in
                    the regulation of exosome composition and NKG2D-mediated immune recognition. Front Cell Dev Biol 2016;4:97.  DOI  PubMed
                    PMC
   113   114   115   116   117   118   119   120   121   122   123